
SOLEUS CAPITAL MANAGEMENT, L.P.
Latest 13F filing data - Q1 2026
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
![]() | GERN | 41.51M | $61.85M |
![]() | IKT | 10.88M | $18.27M |
![]() | CERS | 10.75M | $19.57M |
![]() | NVCR | 10.49M | $114.37M |
![]() | ORGO | 10.09M | $23.90M |
![]() | IVVD | 7.71M | $10.02M |
![]() | EDAP | 7.31M | $27.19M |
![]() | CNTX | 6.96M | $18.24M |
![]() | IMUX | 4.50M | $5.00M |
![]() | BBNX | 4.35M | $43.63M |
![]() | TGTX | 4.03M | $133.85M |
![]() | CCCC | 3.80M | $10.00M |
![]() | NPCE | 2.93M | $38.56M |
![]() | LUNG | 2.79M | $3.60M |
![]() | VCEL | 2.55M | $82.00M |
![]() | EOLS | 2.25M | $9.23M |
![]() | PGNY | 2.07M | $35.10M |
![]() | VIR | 2.00M | $17.94M |
![]() | ALKS | 1.97M | $69.69M |
![]() | SOPH | 1.85M | $9.16M |

Geron Corporation
GERN
Shares Held
41.51M
Value
$61.85M

Inhibikase Therapeutics, Inc.
IKT
Shares Held
10.88M
Value
$18.27M

Cerus Corporation
CERS
Shares Held
10.75M
Value
$19.57M

NovoCure Limited
NVCR
Shares Held
10.49M
Value
$114.37M

Organogenesis Holdings Inc.
ORGO
Shares Held
10.09M
Value
$23.90M

Invivyd, Inc.
IVVD
Shares Held
7.71M
Value
$10.02M

Edap Tms S.a.
EDAP
Shares Held
7.31M
Value
$27.19M

Context Therapeutics Inc.
CNTX
Shares Held
6.96M
Value
$18.24M

Immunic, Inc.
IMUX
Shares Held
4.50M
Value
$5.00M

Beta Bionics, Inc.
BBNX
Shares Held
4.35M
Value
$43.63M

TG Therapeutics, Inc.
TGTX
Shares Held
4.03M
Value
$133.85M

C4 Therapeutics, Inc.
CCCC
Shares Held
3.80M
Value
$10.00M

NeuroPace, Inc.
NPCE
Shares Held
2.93M
Value
$38.56M

Pulmonx Corporation
LUNG
Shares Held
2.79M
Value
$3.60M

Vericel Corporation
VCEL
Shares Held
2.55M
Value
$82.00M

Evolus, Inc.
EOLS
Shares Held
2.25M
Value
$9.23M

Progyny, Inc.
PGNY
Shares Held
2.07M
Value
$35.10M

Vir Biotechnology, Inc.
VIR
Shares Held
2.00M
Value
$17.94M

Alkermes plc
ALKS
Shares Held
1.97M
Value
$69.69M

SOPHiA GENETICS S.A.
SOPH
Shares Held
1.85M
Value
$9.16M
